Sample size calculations in pediatric clinical trials conducted in an ICU: A systematic review

Trials

Volumn 15, Issue 1, 2014, Pages

  Nikolakopoulos, Stavros ^a   Roes, Kit C B ^a   van der Lee, Johanna H ^b   van der Tweel, Ingeborg ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Clinical trials; Event rate; Power; Sample size; Standard deviation; Study design

Indexed keywords

CALCULATION; CLINICAL ASSESSMENT; EFFECT SIZE; HUMAN; INTENSIVE CARE UNIT; NEWBORN INTENSIVE CARE; PHARMACEUTICAL CARE; PUBLICATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SAMPLE SIZE; SYSTEMATIC REVIEW; TREATMENT OUTCOME; CLINICAL TRIAL (TOPIC); INFANT; INTENSIVE CARE; NEWBORN; PROCEDURES; STATISTICAL ANALYSIS; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA;

CLINICAL TRIALS AS TOPIC; DATA INTERPRETATION, STATISTICAL; HUMANS; INFANT; INFANT, NEWBORN; INTENSIVE CARE; INTENSIVE CARE UNITS, NEONATAL; INTENSIVE CARE UNITS, PEDIATRIC; INTENSIVE CARE, NEONATAL; MODELS, STATISTICAL; SAMPLE SIZE;

EID: 84903805824     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-15-274     Document Type: Review

References (33)

1. Noordzij M, Tripepi G, Dekker FW, Zoccali C, Tanck MW, Jager KJ. Sample size calculations: basic principles and common pitfalls. Nephrol Dial Transplant 2010, 25:1388-1393.
2. Schulz KF, Grimes DA. Sample size calculations in randomised trials: mandatory and mystical. Lancet 2005, 365:1348-1353.
3. Eng J. Sample size estimation: how many individuals should be studied?. Radiology 2003, 227:309-313.
4. Halpern SD, Karlawish JH, Berlin JA. The continuing unethical conduct of underpowered clinical trials. JAMA 2002, 288:358-362.
5. Schulz KF, Altman DG, Moher D, . CONSORT Group CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ 2010, 340:c332. CONSORT Group.
6. Harmonised ICH, . Tripartite Guideline Statistical principles for clinical trials: International Conference on Harmonisation E9 expert working group. Stat Med 1999, 18:1905-1942. Tripartite Guideline.
7. De Angelis CD, Drazen JM, Frizelle FA, Haug C, Hoey J, Horton R, Kotzin S, Laine C, Marusic A, Overbeke AJ, Schroeder TV, Sox HC, Van Der Weyden MB. Is this clinical trial fully registered? - A statement from the International Committee of Medical Journal Editors. N Engl J Med 2005, 352:2436-2438.
8. Pasquali SK, Lam WK, Chiswell K, Kemper AR, Li JS. Status of the pediatric clinical trials enterprise: an analysis of the US ClinicalTrials.gov registry. Pediatrics 2012, 130(5):1269-1277.
9. Hartling L, Wittmeier KD, Caldwell P, van der Lee H, Klassen TP, Craig JC, Offringa M, . StaR Child Health Group StaR child health: developing evidence-based guidance for the design, conduct, and reporting of pediatric trials. Pediatrics 2012, 129(Suppl 3):S112-S117. StaR Child Health Group.
10. Wittmeier KD, Craig J, Klassen TP, Offringa M. The mission of StaR Child Health is to improve the quality of the design, conduct, and reporting of pediatric clinical research by promoting the use of modern research standards. Intro Pediatr 2012, 129(Suppl 3):S111.
11. Caldwell PH, Murphy SB, Butow PN, Craig JC. Clinical trials in children. Lancet 2004, 364:803-811.
12. Klassen TP, Hartling L, Craig JC, Offringa M. Children are not just small adults: the urgent need for high-quality trial evidence in children. PLoS Med 2008, 5:e127.
13. Food and Drug Administration International conference on harmonisation; guidance on E11 clinical investigation of medicinal products in the pediatric population; availability: notice. Fed Regist 2000, 65:78493-78494. Food and Drug Administration.
14. Conroy S, McIntyre J, Choonara I, Stephenson T. Drug trials in children: problems and the way forward. Br J Clin Pharmacol 2000, 49:93-97.
15. Bosch X. Pediatric medicine: Europe follows US in testing drugs for children. Science 2005, 309:1799.
16. Caldwell PH, Butow PN, Craig JC. Parents' attitudes to children's participation in randomized controlled trials. J Pediatr 2003, 142:554-559.
17. Sureshkumar P, Caldwell P, Lowe A, Simpson JM, Williams G, Craig JC. Parental consent to participation in a randomised trial in children: associated child, family, and physician factors. Clin Trials 2012, 9:645-651.
18. Laventhal N, Tarini BA, Lantos J. Ethical issues in neonatal and pediatric clinical trials. Pediatr Clin North Am 2012, 59:1205-1220.
19. Gill D, . Ethics Working Group of the Confederation of European Specialists in Paediatrics Ethical principles and operational guidelines for good clinical practice in paediatric research. Recommendations of the Ethics Working Group of the Confederation of European Specialists in Paediatrics (CESP). Eur J Pediatr 2004, 163:53-57. Ethics Working Group of the Confederation of European Specialists in Paediatrics.
20. van der Lee JH, Tanck MW, Wesseling J, Offringa M. Pitfalls in the design and analysis of paediatric clinical trials: a case of a 'failed' multi-centre study, and potential solutions. Acta Paediatr 2009, 98:385-391.
21. Proschan MA. Two-stage sample size re-estimation based on a nuisance parameter: a review. J Biopharm Stat 2005, 15:559-574.
22. Vickers AJ. Underpowering in randomized trials reporting a sample size calculation. J Clin Epidemiol 2003, 56:717-720.
23. Kraemer HC, Mintz J, Noda A, Tinklenberg J, Yesavage JA. Caution regarding the use of pilot studies to guide power calculations for study proposals. Arch Gen Psychiatry 2006, 63:484-489.
24. Sim J, Lewis M. The size of a pilot study for a clinical trial should be calculated in relation to considerations of precision and efficiency. J Clin Epidemiol 2012, 65:301-308.
25. Cohen J. A power primer. Psychol Bull 1992, 112:155-159.
26. Chan AW, Hrobjartsson A, Jorgensen KJ, Gotzsche PC, Altman DG. Discrepancies in sample size calculations and data analyses reported in randomised trials: comparison of publications with protocols. BMJ 2008, 337:a2299.
27. Charles P, Giraudeau B, Dechartres A, Baron G, Ravaud P. Reporting of sample size calculation in randomised controlled trials: review. BMJ 2009, 338:b1732.
28. The Cochrane collaboration. [http://www.cochrane-handbook.org].
29. Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 2005, 5:13.
30. Chuang-Stein C, Kirby S, Hirsch I, Atkinson G. The role of the minimum clinically important difference and its impact on designing a trial. Pharm Stat 2011, 10:250-256.
31. Hoenig JM, Heisey DM. The abuse of power: the pervasive fallacy of power calculations for data analysis. Am Statistician 2001, 55:19-24.
32. Altman DG. The scandal of poor medical research. BMJ 1994, 308:283.
33. van der Tweel I, Askie L, Vandermeer B, Ellenberg S, Fernandes RM, Saloojee H, Bassler D, Altman DG, Offringa M, Van der Lee JH, . for the StaR Child Health Group Standard 4: determining adequate sample sizes. Pediatrics 2012, 129(Suppl 3):S138-S145. for the StaR Child Health Group.